Abstract
This study sought to investigate in vivo the vascular response at the proximal and distal edges of the second-generation ABSORB everolimus-eluting bioresorbable vascular scaffold (BVS).
| Original language | English |
|---|---|
| Journal | Circulation. Cardiovascular interventions |
| Volume | 5 |
| Issue number | 6 |
| Pages (from-to) | 656-65 |
| Number of pages | 10 |
| ISSN | 1941-7640 |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- Absorbable Implants
- Aged
- Angioplasty, Balloon, Coronary
- Cardiovascular Agents
- Coronary Artery Disease
- Coronary Vessels
- Drug-Eluting Stents
- Female
- Fibrosis
- Humans
- Male
- Middle Aged
- Predictive Value of Tests
- Prospective Studies
- Prosthesis Design
- Sirolimus
- Time Factors
- Tissue Scaffolds
- Treatment Outcome
- Ultrasonography, Interventional
- Vascular Calcification
Fingerprint
Dive into the research topics of 'Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS